BioRestorative Therapies, Inc. (BRTX) income statement
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.32−0.02 (-1.12%)
Close on Nov 18, 2026Market cap $33.76MP/E –Yield –
BioRestorative Therapies, Inc. income statement
Ratios
Latest available, balances at Mar 31, 2026
Profitability, TTM
- Gross margin
- 92.1%
- Operating margin
- -3975.0%
- Net margin
- -3089.6%
- Return on equity, FY2025
- -320.5%
Financial strength
- Current ratio
- 2.35
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 192.8%
Valuation
- P/E ratio
- –
- Price to sales
- 94.33
- Price to book
- 11.16
- Dividend yield
- –
See a number that looks wrong?